Investing
Business
Stock
Politics

Acceleration of RAD204 Phase 1 dose escalation trial

by admin May 12, 2025

May 12, 2025

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

previous post

Excellent Gold Intersections Verified at Kiimala Project

next post

Multiple New Multi-Commodity Targets

You may also like

Asara Resources

July 7, 2025

FPX Nickel Receives Multi-Year Area-BasedPermit and Commences 2025...

July 7, 2025

Bringing Art, Youth, and Football Together: Kobo’s Workshop...

July 7, 2025

Crypto Market Recap: SEC Crypto ETF Guidance Sets...

July 7, 2025

Canadian Investment Regulatory Organization Trade Resumption – STUD

July 7, 2025

Questcorp Mining Continues Exploration in Advance of Drilling...

July 7, 2025

Tech 5: US Lifts EDA Restrictions for China,...

July 6, 2025

Top 5 Canadian Mining Stocks This Week: Mkango...

July 5, 2025

Stallion Uranium to Resume Trading on the TSX-V and...

July 5, 2025

Lithium Universe LtdInterview with Executive Chairman

July 5, 2025

Join The Exclusive Subscription Today And Get Premium Articles For Free

Your name

Your email

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Recent Posts

Asara Resources

July 7, 2025
FPX Nickel Receives Multi-Year Area-BasedPermit and Commences 2025 Drilling Activities at Baptiste Nickel Project

July 7, 2025
Bringing Art, Youth, and Football Together: Kobo’s Workshop in Kossou

July 7, 2025
Crypto Market Recap: SEC Crypto ETF Guidance Sets Stage for Wave of New Fund Approvals

July 7, 2025
Canadian Investment Regulatory Organization Trade Resumption – STUD

July 7, 2025

About us
Contact us
Privacy Policy
Terms & Conditions

Copyright © 2025 investingcongress.com | All Rights Reserved

Investing
Business
Stock
Politics